{
    "Trade/Device Name(s)": [
        "CardioChek Plus Test System",
        "CardioChek Plus Home Test System"
    ],
    "Submitter Information": "Polymer Technology Systems, Inc. d/b/a PTS Diagnostics",
    "510(k) Number": "K193406",
    "Predicate Device Reference 510(k) Number(s)": [
        "K140068"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "CHH",
        "LBR",
        "JGY"
    ],
    "Summary Letter Date": "October 15, 2020",
    "Summary Letter Received Date": "October 16, 2020",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1175",
        "21 CFR 862.1475",
        "21 CFR 862.1705"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Cholesterol (total) test system",
        "Lipoprotein test system",
        "Triglyceride test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total cholesterol",
        "HDL cholesterol",
        "Glucose",
        "Triglycerides",
        "LDL cholesterol (calculated)"
    ],
    "Specimen Type(s)": [
        "Venous whole blood",
        "Capillary whole blood (fingerstick)"
    ],
    "Specimen Container(s)": [
        "Single-use, auto-disabling lancing devices"
    ],
    "Instrument(s)/Platform(s)": [
        "CardioChek Plus analyzer",
        "CardioChek Plus Home analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Reflectance photometry",
        "Amperometric/electrochemical technology",
        "Enzymatic methods",
        "Dry colorimetric test strips"
    ],
    "Methodologies": [
        "In vitro diagnostic testing",
        "Enzymatic colorimetric assay",
        "Electrochemical measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Test System",
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for CardioChek Plus Test System and CardioChek Plus Home Test System for quantitative measurement of cholesterol, HDL, glucose, and triglycerides in whole blood using analyzer and test strips",
    "Indications for Use Summary": "Quantitative determination of total cholesterol, HDL cholesterol, glucose, and triglycerides in venous or capillary whole blood for diagnosis and treatment of lipid and carbohydrate metabolism disorders, for use in professional healthcare settings or self-testing.",
    "fda_folder": "Clinical Chemistry"
}